Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Oct 1;138(4):887–889. doi: 10.1084/jem.138.4.887

EFFECT OF IMMUNOSUPPRESSION ON CHRONIC LCM VIRUS INFECTION OF MICE

Phillip E Hoffsten 1, Frank J Dixon 1
PMCID: PMC2180570  PMID: 4270346

Abstract

C3H mice chronically infected with LCM virus were found to be lethally affected by small doses of immunosuppression which caused bone marrow aplasia but had no effect on the amount of virus carried by the mouse. Humoral immune response of SWR/J mice to acute LCM infection was found to be totally suppressed by repeated single doses of 300 R/wk with no alteration in the level of virus carried by the mouse. In contrast, the established anti-LCM humoral immune response encountered in mice chronically infected with LCM virus was not suppressed by the same irradiation procedure. Over half of the chronic LCM carrier SWR/J mice treated with cyclophosphamide for 6 mo had total anti-LCM humoral immunosuppression, but showed no change in the level of virus carried. The glomerulonephritis which occurs in chronic LCM carrier mice was prevented by cyclophosphamide treatment in 90% of the mice. The humoral immune response which occurs in chronic LCM carrier mice appears to play no role in controlling the amount of virus carried by the mouse. Suppression of the LCM immune response by cyclophosphamide does prevent the development of glomerulonephritis in these mice.

Full Text

The Full Text of this article is available as a PDF (849.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlmén J., Attman P. O., Bengtsson Y. U. Experience of immunosuppressive therapy of glomerular disease in adults. Acta Med Scand. 1971 Nov;190(5):425–428. doi: 10.1111/j.0954-6820.1971.tb07453.x. [DOI] [PubMed] [Google Scholar]
  2. Booth L. J., Aber G. M. Immunosuppressive therapy in adults with proliferative glomerulonephritis. Controlled trial. Lancet. 1970 Nov 14;2(7681):1010–1013. doi: 10.1016/s0140-6736(70)92817-5. [DOI] [PubMed] [Google Scholar]
  3. Bro-Jorgensen K., Volkert M. Haemopoietic defects in mice infected with lymphocytic choriomeningitis virus. 2. The viral effect upon the function of colony-forming stem cells. Acta Pathol Microbiol Scand B Microbiol Immunol. 1972;80(6):853–862. [PubMed] [Google Scholar]
  4. Cameron J. S. Bright's disease today: the pathogenesis and treatment of glomerulonephritis. II. Br Med J. 1972 Oct 21;4(5833):160–contd. doi: 10.1136/bmj.4.5833.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cheema A., Henson J. B., Gorham J. R. Aleutian disease of mink. Prevention of lesions by immunosuppression. Am J Pathol. 1972 Mar;66(3):543–556. [PMC free article] [PubMed] [Google Scholar]
  6. Dixon F. J. Presidential address. Pathogenesis of immunologic disease. J Immunol. 1972 Aug;109(2):187–192. [PubMed] [Google Scholar]
  7. DuBuy H. G., Worthington M., Johnson M. L. Effect of an immunosuppressive agent, cyclophosphamide, on chronic lactic dehydrogenase virus viremia of mice. Infect Immun. 1971 Dec;4(6):720–724. doi: 10.1128/iai.4.6.720-724.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HOTCHIN J., WEIGAND H. The effects of pretreatment with x-rays on the pathogenesis of lymphocytic choriomeningitis in mice. I. Host survival, virus multiplication and leukocytosis. J Immunol. 1961 Dec;87:675–681. [PubMed] [Google Scholar]
  9. Holland N. H., Bennett N. M. Hypocomplementemic (membranoproliferative) glomerulonephritis. Immunosuppressive therapy. Am J Dis Child. 1972 May;123(5):439–445. doi: 10.1001/archpedi.1972.02110110067001. [DOI] [PubMed] [Google Scholar]
  10. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  11. Notkins A. L., Mahar S., Scheele C., Goffman J. Infectious virus-antibody complex in the blood of chronically infected mice. J Exp Med. 1966 Jul 1;124(1):81–97. doi: 10.1084/jem.124.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Oldstone M. B., Dixon F. J. Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science. 1967 Dec 1;158(3805):1193–1195. doi: 10.1126/science.158.3805.1193. [DOI] [PubMed] [Google Scholar]
  13. Oldstone M. B., Dixon F. J. Pathogenesis of chronic disease associated with persistent lymphocytic choriomeningitis viral infection. I. Relationship of antibody production to disease in neonatally infected mice. J Exp Med. 1969 Mar 1;129(3):483–505. doi: 10.1084/jem.129.3.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Oldstone M. B., Dixon F. J. Susceptibility of different mouse strains to lymphocytic choriomeningitis virus. J Immunol. 1968 Feb;100(2):355–357. [PubMed] [Google Scholar]
  15. ROWE W. P. Protective effect of pre-irradiation on lymphocytic choriomeningitis infection in mice. Proc Soc Exp Biol Med. 1956 May;92(1):194–198. doi: 10.3181/00379727-92-22425. [DOI] [PubMed] [Google Scholar]
  16. Russell P. J., Hicks J. D. Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet. 1968 Mar 2;1(7540):440–441. doi: 10.1016/s0140-6736(68)92778-5. [DOI] [PubMed] [Google Scholar]
  17. SUTTON W. T., VAN HAGEN, GRIFFITH B. H., PRESTON F. W. DRUG EFFECTS ON SURVIVAL OF HOMOGRAFTS OF SKINS. Arch Surg. 1963 Nov;87:840–843. doi: 10.1001/archsurg.1963.01310170126021. [DOI] [PubMed] [Google Scholar]
  18. Sharon N., Pollard M. Effects of cyclophosphamide on lesions induced by persistent LCM virus infection in gnotobiotic mice. Arch Gesamte Virusforsch. 1971;34(4):278–286. doi: 10.1007/BF01242973. [DOI] [PubMed] [Google Scholar]
  19. Strauss M. B. Immunosuppressive treatment of proliferative glomerulonephritis. N Engl J Med. 1971 Sep 9;285(11):632–633. doi: 10.1056/NEJM197109092851111. [DOI] [PubMed] [Google Scholar]
  20. UHR J. W., SCHARFF M. Delayed hypersensitivity. V. The effect of x-irradiation on the development of delayed hypersensitivity and antibody formation. J Exp Med. 1960 Jul 1;112:65–76. doi: 10.1084/jem.112.1.65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Urizar R. E., Tinglof B., McIntosh R., Litman N., Barnett E., Wilkerson J., Smith F., Jr, Vernier R. L. Immunosuppressive therapy of proliferative glomerulonephritis in children. Am J Dis Child. 1969 Sep;118(3):411–425. doi: 10.1001/archpedi.1969.02100040413001. [DOI] [PubMed] [Google Scholar]
  22. Walker S. E., Bole G. G. Augmented incidence of neoplasia in female New Zealand black-New Zealand white (NZB-NZW) mice treated with long-term cyclophosphamide. J Lab Clin Med. 1971 Dec;78(6):978–979. [PubMed] [Google Scholar]
  23. White R. H., Cameron J. S., Trounce J. R. Immunosuppressive therapy in steroid-resistant proliferative glomerulonephritis accompanied by the nephrotic syndrome. Br Med J. 1966 Oct 8;2(5518):853–860. doi: 10.1136/bmj.2.5518.853. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES